Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996

JAMA

Volumn 284, Issue 2, 2000, Pages 229-235

  Glynn, Simone A ^a   Kleinman, Steven H ^b   Schreiber, George B ^b   Busch, Michael P ^b   Wright, David J ^b   Smith, James W ^b   Nass, Catharie C ^b   Williams, Alan E ^b  

^a WESTAT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAFETY; SCREENING; SEROPREVALENCE; UNITED STATES; VIRUS INFECTION;

EID: 0034641269     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.2.229     Document Type: Article

References (33)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685-1690.
2. Lackritz EM, Satten GA, Aberle-Crasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med. 1995;333:1721-1725.
3. Kleinman S, Busch MP, Korelitz JJ, Schreiber CB. The Incidence/window period model and Its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus Med rev. 1997;11:155-172.
4. Kleinman S. Blood donor screening: principles and policies. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RC, eds. Clinical Practice of Transfusion Medicine. 3rd ed. New York, NY: Churchill Livingstone Inc; 1996:245-270.
5. Busch MP, Stramer SL, Kleinman SH. Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives. In: CarrattyC, ed. Applicationsof Molecular Biology in Blood Transfusion. Bethesda, Md: American Association of Blood Banks; 1997:123-176.
6. Ward JW, Duchin JS.The epidemiology of HIV and AIDS In the United States. AIDS Clin Rev. 1997-98: 1-45.
7. Busch MP, Laycock M, Kleinman SH, et al. Accuracy of supplementary sérologie testing for human T-lymphotropic virus types I and II in US blood donors. Blood. 1994;83:1143-1148.
8. Kleinman S, Busch MP, Hall L, etal. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. JAMA. 1998;280:1080-1085.
9. Kleinman S, Busch M, Rawal B, Glynn S. Evaluation of HBsAg neutralization test positive donor: with negative anti-HBc [abstract]. Transfusion. 1998;38S:92S.
10. SAS Institute Inc. The CATMOD procedure. In: SAS/STST User's Guide. 4th éd. Cary, NC: SAS Institute Inc; 1989:405-517.
11. Wright DJ, Glynn S, Busch M, et al. A proposed new method to estimate hepatitis B incidence rates based on HBsAg marker [abstract]. Tramfusion. 1999; 395:1065.
12. Korelitz JJ, Busch MP, Kleinman SH, et al. A method for estimating hepatitis B virus incidence rates in volunteer blood donors. Transfusion. 1997;37:634-640.
13. Test of hypotheses, the chi-square test of goodness of fit. In: Snedecor GW, Cochran WG, eds. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:75-78.
14. Zuck TF. Transfusion-transmitted AIDS reassessed. N Engl J Med. 1988;318:511-512.
15. Busch MP, Young MJ, Samson SM, et al. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. Transfusion. 1991;31:4-11.
16. Busch MP. Retroviruses and blood transfusions: the lessons learned and the challenge yet ahead. In: Nance SJ, ed. Blood Safety: Current Challenges. Bethesda, Md: American Association of Blood Banks; 1992:1-44.
17. GummingPD, Wallace EL, SchorrJB, Dodd RY. Exposure of patients to human immunodeficiency virus through the transfusion of blood components thattest antibody-negative. W Engl J Med. 1989;321:941-946.
18. Karon JM, Rosenberg PS, McQuillan G, et al. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA. 1996;276:126-131.
19. Alter HJ, Conry-Cantilena C, Melpolder J, et al. Hepatitis C in asymptomatic blood donors. Hepatology. 1997;26(3 suppl 1):29S-33S.
20. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. W Engl J Med. 1999; 341:556-562.
21. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep. 1998;47 (RR-19):1-39.
22. Alter AAJ. Epidemiology of hepatitis C. Hepatology. 1997;26(3 suppl 1):62S-65S.
23. Bastiaans Ml, Nath N, Dodd RY, Barker LF. Hepatitis-associated markers in the American Red Cross volunteer blood donor population. Vox Sang. 1982;42: 203-210.
24. Dodd R, Nath N, Bastiaans MJ, Barker L. Hepatitis associated markers in the American Red Cross donor population. In: Szmuness W, Alter H, Maynard JE, eds. Viral Hepatitis. Philadelphia, Pa: The Franklin Institute Press; 1982:145-155.
25. Coleman PJ, McQuillan CM, Moyer LA, et al. Incidence of hepatitis B virus infection in the United States, 1976-1994. J Infect Dis. 1998;178:954-959.
26. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Castroenterol Clin North Am. 1994;23:437-455.
27. Human T-lymphotropic virus type I screening in volunteer blood donors-United States, 1989. MMWR Morb Mortal Wkly Rep. 1990;39:915, 921-924.
28. Kaplan JE, Khabbaz RF. HTLV-I: newest addition to blood donor screening. Am Fam Physician. 1989; 40:189-195.
29. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992;326:375-380.
30. Kleinman SH, Kaplan JE, Khabbaz RF, et al. Evaluation of a p21e-spiked Western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. J Clin Microbiol. 1994;32:603-607.
31. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA. 1997;277:967-972.
32. Janssen RS, Satten CA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAM A. 1998;280:42-48.
33. Kleinman S, Williams AE. Donor selection procedures Transfus Meet Rev. 1998;12:288-302.